Phototherapy with turquoise versus blue light

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 5, 2003, Pages

  Ebbesen, F ^a   Agati, G ^b   Pratesi, R ^c  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b CNR   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILIRUBIN BLOOD LEVEL; BLUE LIGHT; CALIBRATION; COMPARATIVE STUDY; CONTROLLED STUDY; EYE IRRITATION; FEMALE; FLUORESCENCE; GLARE; HEADACHE; HUMAN; INFANT; LIGHT; LIGHT ABSORPTION; LIGHT IRRADIANCE; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; PREMATURITY; PRIORITY JOURNAL; SAFETY; TREATMENT OUTCOME; TURQUOISE LIGHT; VERTIGO; VISUAL IMPAIRMENT;

EID: 0043263926     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.88.5.f430     Document Type: Article

References (4)

1. Agati G, Fusi F, Donzelli GP, et al. Quantum yield and skin filtering effects on the formation rate of lumirubin. J Photochem Photobiol B 1993;18:197-203.
2. Donzelli GP, Pratesi S, Rapisardi G, et al. 1-day phototherapy of neonatal jaundice with blue-green lamp. Lancet 1995;346:184-5.
3. Rosenstein BS, Ducore JM. Induction of DNA strand breaks in normal human fibroblasts exposed to monochromatic ultraviolet and visible wavelengths in the 240-546 nm range. Photochem Photobiol 1983;38:51-5.
4. Rudolph N, Parekh AJ, Hittelman J, et al. Postnatal decline in pyridoxal phosphate and riboflavin. Accentuation by phototherapy. American Journal of Diseases in Children 1985;139:812-15.